THURSDAY, Sept. 19, 2024 -- For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer...

TUESDAY, Sept. 17, 2024 -- The delivery of early, virtual palliative care has similar effects on quality of life as in-person care in patients with...

THURSDAY, Sept. 26, 2024 -- For patients with primary progressive multiple sclerosis (PPMS), the time to confirmed disability progression (CDP) does...

FRIDAY, Sept. 27, 2024 -- Reducing or preventing paramagnetic rim lesions (PRLs) could significantly slow multiple sclerosis (MS) progression,...

FRIDAY, Sept. 20, 2024 -- Disease-free survival is significantly longer with adjuvant pembrolizumab than observation among patients with high-risk...

FRIDAY, Sept. 20, 2024 -- For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left...

TUESDAY, Sept. 17, 2024 -- For postoperative patients with breast cancer, the duration of aromatase inhibitor (AI) treatment is not associated with...

WEDNESDAY, Sept. 18, 2024 -- For patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT2i) use is associated with reduced...

TUESDAY, Sept. 24, 2024 -- There is a J-shaped association between systemic immune-inflammation index (SII) levels and all-cause mortality in...

TUESDAY, Sept. 17, 2024 -- A new prognostic model can predict and stratify hepatocellular carcinoma (HCC) risk in noncirrhotic adult patients with...